Takeda Pharmaceutical Company Limited:企業のM&A・事業提携・投資動向

◆英語タイトル:Takeda Pharmaceutical Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2130
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:454
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Takeda Pharmaceutical Company Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Takeda Pharmaceutical Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Takeda Pharmaceutical Company Limited since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Takeda Pharmaceutical Company Limited’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Takeda Pharmaceutical Company Limited. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Takeda Pharmaceutical Company Limited’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Takeda Pharmaceutical Company Limited and its subsidiaries since 2007.
- Information about key financial and legal advisors for Takeda Pharmaceutical Company Limited’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Takeda Pharmaceutical Company Limited’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 41
Corporate Venturing – Overview 41
Corporate Venturing – Deal reports 42
PARTNERSHIP 54
Partnership – Overview 54
Partnership – Deal reports 55
CAPITAL RAISING 427
Capital Raising – Deal reports 427
DIVESTMENTS 429
Divestments – Overview 429
Divestments – Deal reports 430
APPENDIX 444
Contact Us 444
About MarketLine Financial Deals Database 444
Deal Definition and Methodology 446
About MarketLine 453

List of Tables
Table 1: Takeda Pharmaceutical Company Limited M&A volume and value trend (2014-YTD2018)
Table 2: Takeda Pharmaceutical Company Limited M&A activity by geography (2014-YTD2018)
Table 3: Takeda Pharmaceutical Company Limited corporate venturing volume and value trend (2014-YTD2018)
Table 4: Takeda Pharmaceutical Company Limited corporate venturing by geography (2014-YTD2018)
Table 5: Takeda Pharmaceutical Company Limited partnership volume and value trend (2014-YTD2018)
Table 6: Takeda Pharmaceutical Company Limited partnership trend by key deal type (2014-YTD2018)
Table 7: Takeda Pharmaceutical Company Limited divestments volume and value trend (2014-YTD2018)
Table 8: Takeda Pharmaceutical Company Limited divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Takeda Pharmaceutical Company Limited M&A volume and value trend (2014-YTD2018)
Figure 2: Takeda Pharmaceutical Company Limited M&A activity by geography (2014-YTD2018)
Figure 3: Takeda Pharmaceutical Company Limited corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Takeda Pharmaceutical Company Limited corporate venturing by geography (2014-YTD2018)
Figure 5: Takeda Pharmaceutical Company Limited partnership volume and value trend (2014-YTD2018)
Figure 6: Takeda Pharmaceutical Company Limited partnership trend by key deal type (2014-YTD2018)
Figure 7: Takeda Pharmaceutical Company Limited divestments volume and value trend (2014-YTD2018)
Figure 8: Takeda Pharmaceutical Company Limited divestments by geography (2014-YTD2018)

★海外企業調査レポート[Takeda Pharmaceutical Company Limited:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mediware Information Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mediware Information Systems Inc (Mediware), a subsidiary of TPG Capital is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solution …
  • Foamix Pharmaceuticals Ltd (FOMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Foamix Pharmaceuticals Ltd (Foamix), formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company’s product candidates include FMX101, a minocycline foam which is intended for the treatment of mod …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Seair Inc:企業の戦略的SWOT分析
    Seair Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • McGill University:製薬・医療:M&Aディール及び事業提携情報
    Summary McGill University (McGill) is a medical-doctoral university. The institute offers undergraduate, graduate, post-graduate courses besides research programs. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, e …
  • Yandex NV (YNDX):企業の財務・戦略的SWOT分析
    Yandex NV (YNDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SMART Global Holdings, Inc. (SGH):企業の財務・戦略的SWOT分析
    SMART Global Holdings, Inc. (SGH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Itochu Corp (8001):石油・ガス:M&Aディール及び事業提携情報
    Summary Itochu Corp (Itochu) is a trading company. It offers domestic trading, import and export, and overseas trading. The company trades in products such as textile, machinery, metals, minerals, energy, chemicals, food, general products, information and communications technology, realty, insurance …
  • Solvay Group:企業のM&A・事業提携・投資動向
    Solvay Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Solvay Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Lucigen Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • Exterran Corp (EXTN):石油・ガス:M&Aディール及び事業提携情報
    Summary Exterran Corp (Exterran) is an energy service company that provides compression, production and processing products; and offers services that support the production and transportation of oil and natural gas. The company owns and operates natural gas compression equipment; and crude oil and n …
  • Motiva Enterprises LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Motiva Enterprises LLC (Motiva), a subsidiary of Saudi Refining, Inc., is downstream oil and gas company, which refines, distributes and markets fuels. The company refines and produces commercial aviation fuel, conventional gasoline, high cetane diesel, ultra-low sulfur diesel, base oils, co …
  • AssetCo plc (ASTO):企業の財務・戦略的SWOT分析
    Summary AssetCo plc (AssetCo) is a business and consumer service provider that offers fire fighting solutions. The company offers provision of management and resources to the fire and emergency services. It also provides outsourced fire and rescue services including the provision of personnel, train …
  • Piramal Enterprises Ltd (PEL)-医療機器分野:企業M&A・提携分析
    Summary Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. I …
  • Tokuyama Corp (4043):電力:M&Aディール及び事業提携情報
    Summary Tokuyama Corp (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, methylene …
  • Beckman Coulter Inc:医療機器:M&Aディール及び事業提携情報
    Summary Beckman Coulter Inc (Beckman), is a subsidiary of Danaher Corp, is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. The company offe …
  • Revolution Lighting Technologies Inc (RVLT):電力:M&Aディール及び事業提携情報
    Summary Revolution Lighting Technologies Inc (Revolution) is a lighting company that designs, manufactures, markets and sells light-emitting diode (LED) lighting products. The company's comprehensive products portfolio includes signage, media and accent lighting, interior and exterior LED lamps and …
  • China Everbright Ltd (165):企業の財務・戦略的SWOT分析
    China Everbright Ltd (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Eu Yan Sang International Ltd:企業の戦略的SWOT分析
    Eu Yan Sang International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Taita Chemical Co Ltd (1309):企業の財務・戦略的SWOT分析
    Taita Chemical Co Ltd (1309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆